Read + Share
Amedeo Smart
Independent Medical Education
Dal-Re R. [Aducanumab approval for Alzheimer's disease in the USA: the surrender of science]. Rev Neurol 2021;73:296-297.PMID: 34617583
Email
LinkedIn
Facebook
Twitter
Privacy Policy